Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Enterprise Value (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Enterprise Value for 5 consecutive years, with -$20.2 million as the latest value for Q3 2020.

  • On a quarterly basis, Enterprise Value rose 21.03% to -$20.2 million in Q3 2020 year-over-year; TTM through Sep 2020 was -$20.2 million, a 21.03% increase, with the full-year FY2019 number at -$6.9 million, up 83.0% from a year prior.
  • Enterprise Value was -$20.2 million for Q3 2020 at Forte Biosciences, up from -$27.7 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$4.1 million in Q3 2016 to a low of -$76.1 million in Q2 2017.
  • A 5-year average of -$24.5 million and a median of -$20.2 million in 2020 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: plummeted 1730.77% in 2017, then surged 83.0% in 2019.
  • Forte Biosciences' Enterprise Value stood at -$5.5 million in 2016, then crashed by 552.14% to -$35.9 million in 2017, then dropped by 13.58% to -$40.8 million in 2018, then soared by 83.0% to -$6.9 million in 2019, then plummeted by 191.11% to -$20.2 million in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Enterprise Value are -$20.2 million (Q3 2020), -$27.7 million (Q2 2020), and -$14.2 million (Q1 2020).